| Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study M Tunca, H Ozdogan, O Kasapcopur, F Yalcinkaya, E Tutar, R Topaloglu, ... Medicine (Baltimore) 84 (1), 1-11, 2005 | 994 | 2005 |
| Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations HJ Lachmann, B Şengül, TU Yavuzşen, DR Booth, SE Booth, A Bybee, ... Rheumatology 45 (6), 746-750, 2006 | 516 | 2006 |
| A Turkish version of the bath ankylosing spondylitis disease activity index: reliability and validity Y Akkoc, AG Karatepe, S Akar, Y Kirazli, N Akkoc Rheumatology international 25, 280-284, 2005 | 374 | 2005 |
| Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever I Touitou, T Sarkisian, M Medlej‐Hashim, M Tunca, A Livneh, D Cattan, ... Arthritis & Rheumatism 56 (5), 1706-1712, 2007 | 323 | 2007 |
| Takayasu's arteritis in Turkey—clinical and angiographic features of 248 patients M Bicakcigil, K Aksu, S Kamali, Z Ozbalkan, A Ates, O Karadag, HTE Ozer, ... Clinical & Experimental Rheumatology 27 (1), S59, 2009 | 267 | 2009 |
| The genetic basis of autosomal dominant familial Mediterranean fever DR Booth, JD Gillmore, HJ Lachmann, SE Booth, A Bybee, M Soytürk, ... Qjm 93 (4), 217-221, 2000 | 251 | 2000 |
| Acute phase response and evolution of familial Mediter ranean fever M Tunca, G Kirkali, M Soytürk, S Akar, MB Pepys, PN Hawkins The Lancet 353 (9162), 1415, 1999 | 251 | 1999 |
| Prevalence of ankylosing spondylitis and related spondyloarthritides in an urban area of Izmir, Turkey. F Onen, S Akar, M Birlik, I Sari, MA Khan, O Gurler, A Ergor, M Manisali, ... The Journal of rheumatology 35 (2), 305-309, 2008 | 234 | 2008 |
| Impaired endothelial function in patients with ankylosing spondylitis I Sari, T Okan, S Akar, H Cece, C Altay, M Secil, M Birlik, F Onen, N Akkoc Rheumatology 45 (3), 283-286, 2006 | 232 | 2006 |
| Identification of multiple genetic susceptibility loci in Takayasu arteritis G Saruhan-Direskeneli, T Hughes, K Aksu, G Keser, P Coit, SZ Aydin, ... The American Journal of Human Genetics 93 (2), 298-305, 2013 | 198 | 2013 |
| Familial Mediterranean Fever (FMF) in Turkey FMF Turkish Medicine 84 (1), 1-11, 2005 | 193 | 2005 |
| Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: a multicentre study T Kasifoglu, SY Bilge, I Sari, D Solmaz, S Senel, H Emmungil, L Kilic, ... Rheumatology 53 (4), 741-745, 2014 | 157 | 2014 |
| Assessment of disease activity and progression in Takayasu’s arteritis with Disease Extent Index-Takayasu SZ Aydin, N Yilmaz, S Akar, K Aksu, S Kamali, E Yucel, O Karadag, ... Rheumatology 49 (10), 1889-1893, 2010 | 151 | 2010 |
| The Turkish versions of the bath ankylosing spondylitis and dougados functional indices: reliability and validity AG Karatepe, Y Akkoc, S Akar, Y Kirazli, N Akkoc Rheumatology international 25, 612-618, 2005 | 150 | 2005 |
| The efficacy of interferon alpha on colchicine-resistant familial Mediterranean fever attacks: a pilot study. M Tunca, E Tankurt, H Akbaylar Akpinar, S Akar, N Hizli, O Gönen British journal of rheumatology 36 (9), 1005-1008, 1997 | 136 | 1997 |
| The prevalence of rheumatoid arthritis in an urban population of Izmir-Turkey S Akar, M Birlik, O Gurler, I Sari, F Onen, M Manisali, K Tirpan, T Demir, ... Clinical and experimental rheumatology 22, 416-420, 2004 | 134 | 2004 |
| Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis A Taylan, I Sari, B Akinci, S Bilge, D Kozaci, S Akar, A Colak, H Yalcin, ... BMC musculoskeletal disorders 13, 1-7, 2012 | 123 | 2012 |
| The effect of interferon alpha administration on acute attacks of familial Mediterranean fever: A double-blind, placebo-controlled trial M Tunca, S Akar, M Soyturk, G Kirkali, H Resmi, H Akhunlar, O Gonen, ... Clinical and experimental rheumatology 22 (4), 2004 | 123 | 2004 |
| Comparison of group-based exercise versus home-based exercise in patients with ankylosing spondylitis: effects on Bath Ankylosing Spondylitis Indices, quality of life and … H Karapolat, Y Akkoc, İ Sarı, S Eyigor, S Akar, Y Kirazlı, N Akkoc Clinical rheumatology 27, 695-700, 2008 | 116 | 2008 |
| Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID-19 Z Izadi, EJ Brenner, SK Mahil, N Dand, ZZN Yiu, M Yates, RC Ungaro, ... JAMA network open 4 (10), e2129639-e2129639, 2021 | 106 | 2021 |
Ismail SariDokuz Eylul University School of Medicine Department of Internal Medicine Division of RheumatologyVerified email at deu.edu.tr
